Introducing the sidekick for drug developers: say hello to the Supor Prime filter!
🌟 Boost your yields
🛡️ Stop blockages
💸 Cut costs
💊 Easier to self administer
Read about it here: https://t.co/D3evIygVla
We promise to tackle climate change head-on.
To help our planet thrive, we’re tackling climate change and making smarter use of resources.
#WeAreCytiva#sustainability#climatechange
The move comes after a study by an ocean conservation group found that Amazon generated 599 million pounds of plastic packaging waste in 2020 https://t.co/tHfJYmwxxe
A research project based at Heidelberg University and Heidelberg University Hospital targets plastic particles and climate change as driving factors for the spread of antimicrobial resistance (AMR) in the environment. https://t.co/911w2Qtmmm?
Emmanuel Abate, President of Genomic Medicine and Head of Sustainability, Cytiva, outlines that the advent of gene and cell therapies, as well as mRNA technology, represents a paradigm shift in the treatment of complex diseases. https://t.co/hq1Q0Pdoqf
Say hello to Sefia! 👋
Sefia is a flexible, modular cell therapy manufacturing platform developed to help drug developers and larger healthcare providers accelerate their CAR T cell therapies production and other cell-based treatments, at a lower cost. https://t.co/VF5pRWTFU2
The life sciences industry is facing a talent crunch. Could developing predictive digital tools help?
Read our Paid Post on The New York Times site: https://t.co/c5Cy4LgPfh
Choosing from the seemingly endless options for mAb manufacturing can feel really overwhelming. We simplify the complex.
Need some help with mAbs? Learn more: https://t.co/TRHDj10TTI
#Cytiva#mAbs#bioprocessing
Say hello to Sefia!
Sefia is our new cell therapy manufacturing platform developed to tackle challenges with manufacturing autologous CAR T cell therapies.
Read more now. https://t.co/An4fdAfPlK